Sanofi’s net sales in the third quarter of 2011 were €8,753 million, an increase of 5.0% on a reported basis. Exchange rate movements had a negative effect of 5.1 percentage points, mainly due to a less favorable euro/U.S. dollar parity.
View post:
Sanofi net sales up 10.1% and Business net income up 4.1% at CER